Levlite, a new low-dose oral contraceptive

September 1998

Berlex is promoting Levlite, a new low-dose oral contraceptive.

It's another "20 mcg pill"...like Alesse, Mircette, and Loestrin 1/20. In fact, Levlite is the SAMEformula as Alesse.

Levlite contains 20 mcg ethinyl estradiol and 100 mcg levo-norgestrel...a third less than the dose inLevlen or Nordette.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

whether hormone replacement therapy reduces the risk of heart disease
Antidepressants new antidepressant called Celexa (citalopram)
Antidepressants realizing that SSRI's can cause weight GAIN
Ophthalmology eye drop bottles don't last as long as they should
Cardiology recommendations for using Viagra in patients with heart disease
Cardiology warning that Ticlid can cause another serious blood disorder
saw palmetto provides SYMPTOMATIC benefit in men with benign prostatic hyperplasia (BPH)
More mainstream companies are now coming out with products that contain herbs
Breast Cancer more women with breast cancer treated with a bisphosphonate
Diabetes estrogen helps prevent and treat type 2 diabetes in postmenopausal women
Diabetes Many patients and clinics want to try the new Laser Lancet
Diabetes new warnings of liver dysfunction in patients taking Precose (acarbose)
New guidelines are now out for treating panic disorder
Women's Health CombiPatch, the first combination estrogen and progestin patch for menopausal symptoms
Women's Health Levlite, a new low-dose oral contraceptive
Rheumatoid Arthritis two exciting new drugs for rheumatoid arthritis
Ophthalmology new warnings about Xalatan and hyperpigmentation